Neurocrine Biosciences
NBIX
#1203
Rank
C$22.32 B
Marketcap
$220.50
Share price
-0.96%
Change (1 day)
15.66%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company